REGEN BIOPHARMA, INC.

RGBP ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2024

Total Assets: $161.1K

Liabilities Breakdown FY2024

Total Liabilities: $5.4M